Comment by Old-Individual1732 on 04/02/2025 at 11:42 UTC

2 upvotes, 0 direct replies (showing 0)

View submission: Invivyd Announces Positive Phase 1/2 Clinical Data for VYD2311, a Monoclonal Antibody Designed to be a Superior Alternative to COVID-19 Vaccination for the Broad Population

Unless it's over the counter availability, trying to get a Dr appointment and prescription at peak infection levels, good luck.

Replies

There's nothing here!